Mirae Asset Global Investments
RYTM icon

Mirae Asset Global Investments’s Rhythm Pharmaceuticals RYTM Stock Holding History

Mirae Asset Global Investments’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$341K Sell
3,068
-494
-14% -$44.7K ﹤0.01% 1039
2026
Q1 		$310K Buy
3,562
+319
+10% +$31K ﹤0.01% 1008
2025
Q4 		$347K Buy
3,243
+675
+26% +$71.6K ﹤0.01% 1062
2025
Q3 		$259K Buy
2,568
+110
+4% +$10.2K ﹤0.01% 1089
2025
Q2 		$155K Buy
2,458
+342
+16% +$20.9K ﹤0.01% 1078
2025
Q1 		$116K Buy
2,116
+68
+3% +$3.77K ﹤0.01% 1105
2024
Q4 		$114K Sell
2,048
-163
-7% -$9K ﹤0.01% 1127
2024
Q3 		$114K Buy
2,211
+391
+21% +$18.7K ﹤0.01% 1169
2024
Q2 		$73K Buy
+1,820
New +$72.6K ﹤0.01% 1184
2024
Q1 		– Sell
-29,444
Closed -$1.35M – 2620
2023
Q4 		$1.35M Sell
29,444
-889
-3% -$28K ﹤0.01% 1456
2023
Q3 		$695K Sell
30,333
-3,651
-11% -$81.8K ﹤0.01% 1723
2023
Q2 		$562K Buy
33,984
+22,928
+207% +$414K ﹤0.01% 1892
2023
Q1 		$197K Buy
+11,056
New +$278K ﹤0.01% 2334

Other funds holding RYTM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Mirae Asset Global Investments's RYTM Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Rhythm Pharmaceuticals (RYTM) stake by 14% in Q2 2026, selling an estimated $44.7K and leaving 3,068 shares worth $341K. The position accounts for ﹤0.01% of the portfolio, ranked #1039.

Mirae Asset Global Investments first reported a position in RYTM in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.35M in Q4 2023. 96 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Mirae Asset Global Investments held 3,068 shares of Rhythm Pharmaceuticals worth $341K as of Q2 2026.
  • Mirae Asset Global Investments sold 494 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $44.7K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1039 holding.
  • Mirae Asset Global Investments first reported a position in Rhythm Pharmaceuticals in Q1 2023 and has held it in 13 quarters since.
  • Mirae Asset Global Investments's Rhythm Pharmaceuticals position peaked at $1.35M in Q4 2023.
  • 96 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.